GemPharmatech Hits Day Low of CNY 33.36 Amid Price Pressure

GemPharmatech Co., a midcap player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 6.4% on August 21, 2026. The stock reached an intraday low of CNY 33.36, reflecting a challenging trading session. Over the past week, GemPharmatech has seen a more significant downturn, with a 15.19% decrease, contrasting with the China Shanghai Composite's slight decline of 0.56%. Despite a strong performance over the past month, where the stock surged by 40.78%, its one-year performance shows a return of just -2.41%, indicating a struggle to maintain momentum. Financial metrics reveal a mixed picture for the company. With a market capitalization of CNY 16,474 million, GemPharmatech has a P/E ratio of 29.00 and a return on equity of 7.00%. However, the company has faced challenges, including negative results for the last five consecutive quarters and a debt-equity ratio of -0.40. These factors contribute to a complex outlook for GemPharmatech as it navigates the current market landscape.